// App-Quantinova.ai

BSH2020‐OR‐026 : A 10‐year analysis of outcomes for advanced‐stage Hodgkin lymphoma comparing extended follow‐up of the multinational RATHL trial with real‐world patients treated with ABVD or escalated BEACOPP in the East of England

Researchers

Presenter

  • J. Russell

Principal Investigators

  • A. Fowler

  • M. Karanth

  • C. Saha

  • S. Docherty

  • J. Padayatty

  • K. Maw

  • I. Lentell

  • L. Cooke

  • A. Hodson

  • N. Shah

  • S. Sadullah

  • N. Grigoropoulos

  • W. Qian

  • A. Kirkwood

  • B. Uttenthal

  • P. Johnson

  • G. Follows

Medical Centers

  • Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge

  • Rheumatology Dept, Norfolk and Norwich University Hospital, Norwich

  • Immunology, Peterborough City Hospital, Peterborough, UK

  • Haematology, West Suffolk Hospital, Bury Saint Edmunds

  • Haematology Department, James Paget University Hospitals, Great Yarmouth

  • Haematology, The Queen Elizabeth Hospital, King's Lynn

  • Haematology, Ipswich Hospital, Ipswich

  • Cancer Research UK and University College London Cancer Trials Centre, University College London, London

  • Cancer Research UK Centre, University of Southampton,Southampton,Royaume-uni

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Adcetris

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved